Medical abortion performed in the womens home has shown to be safe and acceptable up to 9 weeks of gestation. Our project is aiming to confirm our hypothesis that it is equally effective, safe and acceptable when the gestation is more advanced, up to 10 weeks of gestation.
The study will include 600 women opting for medical abortion. Women wanting to perform the last part of the abortion in their homes will be invited to participate. 300 women with a pregnancy up to 9 weeks of gestation (63 days) will be compared to 300 women with a gestation length between 64 and 70 days of gestation. The primary endpoints will be number of patients with an incomplete abortion, with a need for surgical or pharmaceutical intervention. Secondary endpoints include duration of bleeding, acceptance and satisfaction with the method and number of additional visits to the clinic/facility. The study will be performed in five abortion clinics in Sweden.
Study Type
OBSERVATIONAL
Enrollment
273
Medical abortion using Mifepristone at the clinic followed by Cytotec at home
Södersjukhuset
Stockholm, Sweden
Number of incomplete abortions
Need for surgical or pharmaceutical intervention
Time frame: 4 weeks after treatment
Duration of bleeding
Measured by diary and questionnaires
Time frame: 4 weeks after treatment
Acceptance and satisfaction of treatment
Questionnaires
Time frame: 4 weeks after treatment
Number of additional visits to the clinic
Time frame: 4 weeks after treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.